Advertisement
Advertisement
U.S. Markets open in 5 hrs 30 mins
Advertisement
Advertisement
Advertisement
Advertisement

Ultimovacs ASA (7UM.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
5.77+0.08 (+1.41%)
As of 09:16AM CEST. Market open.
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    Ultimovacs Announces Plenary Oral Presentation of Phase I Melanoma Trial Results at the 19th International Congress of the Society for Melanoma Research (SMR)

    New clinical data from phase I trial UV1-103, combining UV1 with pembrolizumab in advanced melanoma will be presented Oslo, September 21 2022: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, announced today that further data from its clinical study on the combination of its universal cancer vaccine, UV1, and the PD-1 checkpoint inhibitor, pembrolizumab, will be disclosed in an oral presentation at the 19th International Congress of the

  • GlobeNewswire

    Ultimovacs Announces Publication of Phase I Melanoma Trial Data in Journal of Translational Medicine

    Comprehensive characterization of phase I UV1-checkpoint inhibitor combination trialClinical responses seen in patients with favored and less favored baseline characteristicsT cell activation observed post-treatment in tumors of responding patients Oslo, September 12, 2022: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for the treatment of cancer, announced today the publication of data from its phase I melanoma trial in Journal of Translational

  • GlobeNewswire

    Ultimovacs ASA: New share capital registered

    Oslo, 9 September 2022, Ultimovacs ASA (the "Company") refers to the announcement published on 5 September 2022 regarding the issuance of new shares in connection with the Company's employee incentive program. The share capital increase related to the share issue of 44,000 new shares has been registered in the Norwegian Register of Business Enterprises, and the Company's new share capital is NOK 3,426,576.10, divided into 34,265,761 shares, each with a par value of NOK 0.10. For further informat

Advertisement
Advertisement